Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Leuchter, Andrew F.
and
Cook, Ian A.
2010.
Reply to Kuo and Tsai.
Psychiatry Research,
Vol. 180,
Issue. 1,
p.
61.
YANG, JIAN JUN
ZHOU, ZHI QIANG
and
YANG, CHUN
2011.
Letter to the Editor: Does ketamine exert a fast-acting antidepressant effect via inhibition of pro-inflammatory cytokines?.
Psychological Medicine,
Vol. 41,
Issue. 8,
p.
1787.
Yang, Chun
Zhou, Zhi-qiang
and
Yang, Jian-jun
2011.
Be Prudent of Ketamine in Treating Resistant Depression in Patients with Cancer.
Journal of Palliative Medicine,
Vol. 14,
Issue. 5,
p.
537.
Bares, Martin
Novak, Tomas
Brunovsky, Martin
Kopecek, Miloslav
Stopkova, Pavla
Krajca, Vladimir
and
Höschl, Cyril
2012.
The change of QEEG prefrontal cordance as a response predictor to antidepressive intervention in bipolar depression. A pilot study.
Journal of Psychiatric Research,
Vol. 46,
Issue. 2,
p.
219.
Zarate, Carlos A.
Brutsche, Nancy
Laje, Gonzalo
Luckenbaugh, David A.
Venkata, Swarajya L. Vattem
Ramamoorthy, Anuradha
Moaddel, Ruin
and
Wainer, Irving W.
2012.
Relationship of Ketamine's Plasma Metabolites with Response, Diagnosis, and Side Effects in Major Depression.
Biological Psychiatry,
Vol. 72,
Issue. 4,
p.
331.
Leuchter, Andrew
Cook, Ian A
and
Hunter, Aimee M
2012.
Comment on ‘The use of the EEG in measuring therapeutic drug action: focus on depression and antidepressants’.
Journal of Psychopharmacology,
Vol. 26,
Issue. 8,
p.
1162.
Paul, Evan D
and
Lowry, Christopher A
2013.
Functional topography of serotonergic systems supports the Deakin/Graeff hypothesis of anxiety and affective disorders.
Journal of Psychopharmacology,
Vol. 27,
Issue. 12,
p.
1090.
Khezri, Marzieh Beigom
Ghasemi, Javad
and
Mohammadi, Navid
2013.
Evaluation of the analgesic effect of ketamine as an additive to intrathecal bupivacaine in patients undergoing cesarean section.
Acta Anaesthesiologica Taiwanica,
Vol. 51,
Issue. 4,
p.
155.
Lapidus, Kyle A.B.
Levitch, Cara F.
Perez, Andrew M.
Brallier, Jess W.
Parides, Michael K.
Soleimani, Laili
Feder, Adriana
Iosifescu, Dan V.
Charney, Dennis S.
and
Murrough, James W.
2014.
A Randomized Controlled Trial of Intranasal Ketamine in Major Depressive Disorder.
Biological Psychiatry,
Vol. 76,
Issue. 12,
p.
970.
Sanacora, G
Smith, M A
Pathak, S
Su, H-L
Boeijinga, P H
McCarthy, D J
and
Quirk, M C
2014.
Lanicemine: a low-trapping NMDA channel blocker produces sustained antidepressant efficacy with minimal psychotomimetic adverse effects.
Molecular Psychiatry,
Vol. 19,
Issue. 9,
p.
978.
De Maricourt, P.
Jay, T.
Goncalvès, P.
Lôo, H.
and
Gaillard, R.
2014.
Effet antidépresseur de la kétamine : revue de la littérature sur les mécanismes d’action de la kétamine.
L'Encéphale,
Vol. 40,
Issue. 1,
p.
48.
Hlinka, Jaroslav
and
Hadrava, Michal
2015.
On the danger of detecting network states in white noise.
Frontiers in Computational Neuroscience,
Vol. 9,
Issue. ,
Leuchter, Andrew F.
Hunter, Aimee M.
Krantz, David E.
and
Cook, Ian A.
2015.
Rhythms and blues: modulation of oscillatory synchrony and the mechanism of action of antidepressant treatments.
Annals of the New York Academy of Sciences,
Vol. 1344,
Issue. 1,
p.
78.
Quintana, D S
Guastella, A J
Westlye, L T
and
Andreassen, O A
2016.
The promise and pitfalls of intranasally administering psychopharmacological agents for the treatment of psychiatric disorders.
Molecular Psychiatry,
Vol. 21,
Issue. 1,
p.
29.
Kobayashi, Brian
Cook, Ian A.
Hunter, Aimee M.
Minzenberg, Michael J.
Krantz, David E.
and
Leuchter, Andrew F.
2017.
Can neurophysiologic measures serve as biomarkers for the efficacy of repetitive transcranial magnetic stimulation treatment of major depressive disorder?.
International Review of Psychiatry,
Vol. 29,
Issue. 2,
p.
98.
de Maricourt, Pierre
and
Gaillard, Raphaël
2017.
La découverte des propriétés antidépressives de la kétamine.
Annales Médico-psychologiques, revue psychiatrique,
Vol. 175,
Issue. 7,
p.
665.
Brazil, Inti A.
2017.
Gedragsaanpassing in psychopathie: inzichten uit de cognitieve en neurowetenschappen.
Neuropraxis,
Vol. 21,
Issue. 2,
p.
28.
Del Percio, Claudio
Derambure, Philippe
Noce, Giuseppe
Lizio, Roberta
Bartrés-Faz, David
Blin, Olivier
Payoux, Pierre
Deplanque, Dominique
Méligne, Déborah
Chauveau, Nicolas
Bourriez, Jean Louis
Casse-Perrot, Catherine
Lanteaume, Laura
Thalamas, Claire
Dukart, Juergen
Ferri, Raffaele
Pascarelli, Maria Teresa
Richardson, Jill C.
Bordet, Regis
and
Babiloni, Claudio
2019.
Sleep deprivation and Modafinil affect cortical sources of resting state electroencephalographic rhythms in healthy young adults.
Clinical Neurophysiology,
Vol. 130,
Issue. 9,
p.
1488.
Verdonk, Franck
Petit, Anne-Cécile
Abdel-Ahad, Pierre
Vinckier, Fabien
Jouvion, Gregory
de Maricourt, Pierre
De Medeiros, Gabriela Ferreira
Danckaert, Anne
Van Steenwinckel, Juliette
Blatzer, Michael
Maignan, Anna
Langeron, Olivier
Sharshar, Tarek
Callebert, Jacques
Launay, Jean-Marie
Chrétien, Fabrice
and
Gaillard, Raphael
2019.
Microglial production of quinolinic acid as a target and a biomarker of the antidepressant effect of ketamine.
Brain, Behavior, and Immunity,
Vol. 81,
Issue. ,
p.
361.
Beck, Katherine
Hindley, Guy
Borgan, Faith
Ginestet, Cedric
McCutcheon, Robert
Brugger, Stefan
Driesen, Naomi
Ranganathan, Mohini
D’Souza, Deepak Cyril
Taylor, Matthew
Krystal, John H.
and
Howes, Oliver D.
2020.
Association of Ketamine With Psychiatric Symptoms and Implications for Its Therapeutic Use and for Understanding Schizophrenia.
JAMA Network Open,
Vol. 3,
Issue. 5,
p.
e204693.